BioLineRx , a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for the second quarter ended June 30, 2014.
http://ift.tt/XDLD7E
http://ift.tt/XDLD7E
No comments:
Post a Comment